More Patent Articles

Pharmaceuticals

New Praise, and Pressure, For the Pharma Industry

Amy Fix, partner at Barnes & Thornburg, discusses the effects of the COVID-19 pandemic on the pharmaceutical industry, including the ways that health and safety protocols have affected the R&D process, the pandemic’s impact on the patent and regulatory landscapes, and what the future of the industry may look like.

Read More

Patent

Committed to IP Excellence Today and Tomorrow

John Hayden, principal at Fish & Richardson, talks about the firm’s prowess in the patent prosecution and counseling space, how COVID-19 has affected business, and what he expects to see going in to next year.

Read More

Pharmaceuticals

Life Sciences Litigation Heats Up Around Patent Eligibility And Generics

Fish & Richardson patent litigator Betsy Flanagan talks about the latest trends in high-stakes patent litigation for pharmaceutical companies and the importance of fostering more teams led by women.

Read More